Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Oncogenic epidermal growth factor receptor mutants with tandem duplication: gene structure and effects on receptor function

Abstract

A number of epidermal growth factor receptor (EGFR) deletion mutants have been identified in gliomas, in which the EGFR gene is frequently amplified and rearranged. We have previously characterized the structure of a gene in A-172 human glioma cells that encodes a 190-kDa EGFR mutant with tandem duplication of the tyrosine kinase (TK) and calcium-mediated internalization (CAIN) domains. Here we describe a 185-kDa tandem duplication mutant (TDM) that is expressed in KE and A-1235 glioma cells, along with certain functional characteristics of the mutants. The corresponding transcripts in KE and A-1235 cells contain 1053 additional nucleotides representing an in-frame duplication of exons 18 through 25 which encode the entire TK region and a portion of the CAIN domain. As with duplication of the entire TK/CAIN region (exons 18–26) in A-172 cells, duplication of exons 18–25 is associated with a specific genomic rearrangement between flanking introns. Involved introns contain homology to recombination signal sequence (RSS) heptamers present in the V(D)J region of the T lymphocyte receptor gene. In defined medium, both oncogenic TDM are constitutively autophosphorylated and inefficiently downregulated. High-affinity binding is reduced in EGFR.TDM/18–26, although the t½ of receptor internalization is not prolonged.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Batra SK, Castelino-Prabhu S, Wikstrand CJ, Zhu X, Humphrey PA, Friedman HS and Bigner DD. . 1995 Cell Growth Diff. 6: 1251–1259.

  • Bigner SH, Humphrey PA, Wong AJ, Vogelstein B, Mark J, Friedman HS and Bigner DD. . 1990 Cancer Res. 50: 8017–8022.

  • Blasband AJ, Gilligan DM, Winchell LF, Wong ST, Luetteke NC, Rogers KT and Lee DC. . 1990 Oncogene 5: 1213–1221.

  • Callaghan T, Anctczak M, Flickinger T, Raines M, Myers M and Kung H-J. . 1993 Oncogene 8: 2939–2948.

  • Chen WS, Lazar CS, Lund KA, Welsh JB, Chang CP, Walton GM, Der CJ, Wiley HS, Gill GN and Rosenfeld MG. . 1989 Cell 59: 33–43.

    Article  CAS  Google Scholar 

  • Chu CT, Everiss KD, Wikstrand CJ, Batra SK, Kung H-J and Bigner DD. . 1997 Biochem. J. 324: 855–861.

    Article  CAS  Google Scholar 

  • Di Fiore PP, Pierce JH, Fleming TP, Hazan R, Ullrich A, King CR, Schlessinger J and Aaronson SA. . 1987 Cell 51: 1063–1070.

    Article  CAS  Google Scholar 

  • Ekstrand AJ, James CD, Cavenee WK, Seliger B, Petterson RF and Collins VP. . 1991 Cancer Res. 51: 2164–2172.

  • Etienne MC, Formento JL, Lebrun-Frenay C, Gioanni J, Chatel M, Paquis P, Bernard C, Courdi A, Bensadoun RJ, Pignol JP, Francoual M, Grellier P, Frenay M and Milano G. . 1998 Clin. Cancer Res. 4: 2383–2390.

  • Fenstermaker RA, Ciesielski MJ and Castiglia GJ. . 1998 Oncogene 16: 3435–3443.

    Article  CAS  Google Scholar 

  • Frisa PS, Walter EI, Ling L, Kung H-J and Jacobberger JW. . 1996 Cell Growth Diff. 7: 223–233.

  • Haley JD, Hsuan JJ and Waterfield MD. . 1990 Oncogene 4: 273–283.

  • Huang H-J Su, Nagane M, Klingbeil K, Lin H, Nishikawa R, Xiang-Dong J, Huang C-M, Gill GN, Wiley HS and Cavenee WK. . 1997 J. Biol. Chem. 272: 2927–2935.

    Article  CAS  Google Scholar 

  • Humphrey PA, Wong AJ, Vogelstein B, Zalutsky MR, Fuller GN, Archer GE, Friedman HS, Kwatra MM, Bigner SH and Bigner DD. . 1990 Proc. Natl. Acad. Sci. USA 87: 4207–4211.

  • Humphrey PA, Wong AJ, Vogelstein B, Friedman HS, Werner MH, Bigner DD and Bigner SH. . 1988 Cancer Res. 48: 2231–2238.

  • Humphrey PA, Gangarosa LM, Wong AJ, Archer GE, Lund-Johansen M, Bjerkvig R, Laerum O-D, Friedman HS and Bigner DD. . 1991 Biochem. Res. Comm. 178: 1413–1420.

  • Lehvaslaiho J, Lehtola L, Sistonen L and Alitalo KA. . 1989 EMBO J. 8: 159–166.

  • Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A and Schlessinger J. . 1985 Nature (London) 313: 144–147.

    Article  CAS  Google Scholar 

  • Lund-Johansen M, Bjerkvig R, Humphrey PA, Bigner SH, Bigner D and Laerum O-D. . 1990 Cancer Res. 50: 6039–6044.

  • Maruno M, Kovach JS, Kelly PJ and Yanagihara T. . 1991 J. Neurosurg. 75: 97–102.

  • Montgomery RB, Moscatello DK, Wong AJ, Cooper JA and Stahl WL. . 1995 J. Biol. Chem. 270: 30562–30566.

    Article  CAS  Google Scholar 

  • Moscatello DK, Montgomery RB, Sundareshan P, McDanel H, Wong MY and Wong AJ. . 1996 Oncogene 13: 85–96.

  • Munson PJ and Rodbard D. . 1980 Anal. Biochem. 107: 220–239.

  • Nagane M, Coufal F, Lin H, Bogler O, Cavenee WK and Huang H-J. . 1996 Cancer Res. 56: 5079–5086.

  • Nagane M, Levitzki A, Gazit A, Cavenee WK and Huang HJ. . 1998 Proc. Natl. Acad. Sci. USA 95: 5724–5729.

  • Nishikawa R, Xiang-Dong J, Harmon RC, Lazar CS, Gill GN, Cavenee WK and Huang HJ. . 1994 Proc. Natl. Acad. Sci. USA 91: 7727–7731.

  • O'Rourke DM, Qian X, Zhang H-T, Davis JG, Nute E, Meinkoth J and Greene MI. . 1997 Proc. Natl. Acad. Sci. USA 94: 3250–3255.

  • Panneerselvam K, Kanakaraj P, Raj S, Das M and Bishayee S. . 1995 Eur. J. Biochem. 230: 951–957.

  • Prywes R, Livneh E, Ullrich A and Schlessinger J. . 1986 EMBO J. 5: 2179–2190.

  • Roth DB and Craig NL. . 1998 Cell 94: 411–414.

    Article  CAS  Google Scholar 

  • Schlegel J, Merdes A, Stumm G, Albert FK, Forsting M, Hynes N and Kiessling M. . 1994 Int. J. Cancer 56: 72–77.

  • Steck PA, Lee P, Hung M-C and Yung WKA. . 1988 Cancer Res. 48: 5433–5439.

  • Sugawa N, Ekstrand AJ, James CD and Collins VP. . 1990 Proc. Natl. Acad. Sci. USA 87: 8602–8606.

  • Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Liberman TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD and Seeburg PH. . 1984 Nature (London) 309: 418–425.

    Article  CAS  Google Scholar 

  • Wells A, Welsh JB, Lazar CS, Wiley HS, Gill GN and Rosenfield MG. . 1990 Science 247: 962–964.

    Article  CAS  Google Scholar 

  • Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR and Vogelstein B. . 1987 Proc. Natl. Acad. Sci. USA 84: 6899–6903.

  • Wong AJ, Ruppert JM, Bigner SH, Grzeschik CH, Humphrey PA, Bigner DS and Vogelstein B. . 1992 Proc. Natl. Acad. Sci. USA 89: 2965–2969.

Download references

Acknowledgements

This project was supported by NIH grant CA 16056-22, The Troup Foundation and the Jeffrey Wright Fund.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ciesielski, M., Fenstermaker, R. Oncogenic epidermal growth factor receptor mutants with tandem duplication: gene structure and effects on receptor function. Oncogene 19, 810–820 (2000). https://doi.org/10.1038/sj.onc.1203409

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.onc.1203409

Keywords

This article is cited by

Search

Quick links